Understanding how avian influenza viruses evolve and affect immune responses
NIAID Centers of Excellence for Influenza Research and Response (CEIRR): Avian Influenza Research Activities
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11259414
This study is looking at how the H5N1 bird flu virus spreads and affects both people and animals, with the hope of finding ways to improve vaccines and treatments to keep everyone safer.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11259414 on ClinicalTrials.gov |
What this research studies
This research investigates the factors that influence the evolution and transmission of avian influenza viruses, particularly the H5N1 strain, and how these viruses interact with the immune system. By conducting cohort studies and sampling both humans and animals, the research aims to identify immunological factors that affect disease outcomes and the effectiveness of vaccinations. The goal is to enhance our understanding of how these viruses spread and how to better protect against them through improved vaccines and treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals who have been exposed to avian influenza or are at high risk of exposure, such as poultry workers or those living in areas with outbreaks.
Not a fit: Patients who are not at risk of avian influenza exposure or those with no history of influenza-related complications may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines and treatments for avian influenza, ultimately reducing the risk of outbreaks and improving public health.
How similar studies have performed: Previous research has shown success in understanding influenza virus behavior and immune responses, indicating that this approach has potential for significant advancements.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LOWEN, ANICE — EMORY UNIVERSITY
- Study coordinator: LOWEN, ANICE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Disease Outcome